Unknown

Dataset Information

0

Impact of Intramyocardial Hemorrhage on Clinical Outcomes in ST-Elevation Myocardial Infarction: A Systematic Review and Meta-analysis.


ABSTRACT:

Background

Intramyocardial hemorrhage (IMH) occurs after ST-elevation myocardial infarction (STEMI) and has been documented using cardiac magnetic resonance imaging. The prevalence and prognostic significance of IMH are not well described, and the small sample size has limited prior studies.

Methods

We performed a comprehensive literature search of multiple databases to identify studies that compared outcomes in STEMI patients with or without IMH. The outcomes studied were major adverse cardiovascular events (MACE), infarct size, thrombolysis in myocardial infarction (TIMI) flow after percutaneous coronary intervention (PCI), left ventricular end-diastolic volume (LVEDV), left ventricular ejection fraction (LVEF), and mortality. Odds ratios (ORs) and standardized mean differences with corresponding 95% CIs were calculated using a random effects model.

Results

Eighteen studies, including 2824 patients who experienced STEMI (1078 with IMH and 1746 without IMH), were included. The average prevalence of IMH was 39%. There is a significant association between IMH and subsequent MACE (OR, 2.63; 95% CI, 1.79-3.86; P < .00001), as well as IMH and TIMI grade <3 after PCI (OR, 1.75; 95% CI, 1.14-2.68; P = .05). We also found a significant association between IMH and the use of glycoprotein IIb/IIIa inhibitors (OR, 2.34; 95% CI, 1.42-3.85; P = .0008). IMH has a positive association with infarct size (standardized mean difference, 2.19; 95% CI, 1.53-2.86; P < .00001) and LVEDV (standardized mean difference, 0.7; 95% CI, 0.41-0.99; P < .00001) and a negative association with LVEF (standardized mean difference, -0.89; 95% CI, -1.15 to -0.63; P = .01). Predictors of IMH include male sex, smoking, and left anterior descending infarct.

Conclusions

Intramyocardial hemorrhage is prevalent in approximately 40% of patients who experience STEMI. IMH is a significant predictor of MACE and is associated with larger infarct size, higher LVEDV, and lower LVEF after STEMI.

SUBMITTER: Vyas R 

PROVIDER: S-EPMC11307811 | biostudies-literature | 2022 Nov-Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Impact of Intramyocardial Hemorrhage on Clinical Outcomes in ST-Elevation Myocardial Infarction: A Systematic Review and Meta-analysis.

Vyas Rohit R   Changal Khalid H KH   Bhuta Sapan S   Pasadyn Vanessa V   Katterle Konrad K   Niedoba Matthew J MJ   Vora Keyur K   Dharmakumar Rohan R   Gupta Rajesh R  

Journal of the Society for Cardiovascular Angiography & Interventions 20220826 6


<h4>Background</h4>Intramyocardial hemorrhage (IMH) occurs after ST-elevation myocardial infarction (STEMI) and has been documented using cardiac magnetic resonance imaging. The prevalence and prognostic significance of IMH are not well described, and the small sample size has limited prior studies.<h4>Methods</h4>We performed a comprehensive literature search of multiple databases to identify studies that compared outcomes in STEMI patients with or without IMH. The outcomes studied were major a  ...[more]

Similar Datasets

| S-EPMC5922709 | biostudies-other
| S-EPMC7955417 | biostudies-literature
| S-EPMC10573491 | biostudies-literature
| S-EPMC10858964 | biostudies-literature
| S-EPMC5501718 | biostudies-other
| S-EPMC10961461 | biostudies-literature
| S-EPMC9544509 | biostudies-literature
| S-EPMC9476125 | biostudies-literature
| S-EPMC7823877 | biostudies-literature
| S-EPMC9893338 | biostudies-literature